Crossmark

Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study

Crossref DOI link: https://doi.org/10.1186/s12894-019-0467-3

Published Online: 2019-05-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bock, David https://orcid.org/0000-0001-9111-9602
Angenete, Eva

Bjartell, Anders

Hugosson, Jonas

Steineck, Gunnar

Walming, Sofie

Wiklund, Peter

Haglind, Eva
Funding

Funding for this research was provided by:

Swedish Cancer Foundation (2008/922, 2010/593, 2013/497, 2016/362)

Vetenskapsrådet (2012-1770, 2015-02483)

Västra Götalandsregionen (ALF grants 138751, 146201 and 4307771, HTA–VGR 6011; agreement concerning research and education of doctors)

Anna och Edwin Bergers Stiftelse (N/A)

Stiftelsen Assar Gabrielssons Fond (FB 16-24, 17-18)
License Information

Text and Data Mining valid from 2019-05-08
More Information

Article History

Received: 25 January 2019

Accepted: 25 April 2019

First Online: 8 May 2019

Ethics approval and consent to participate

: In compliance with national guidelines the regional ethics review board of the study secretariat, Gothenburg, Sweden, approved the study (approval 277–07). Written informed consent was obtained from all participants in the trial.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.